Kazuhiko Fukatsu

Dr. Kazuhiko Fukatsu

Surgical Center, The University of Tokyo Hospital, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 1997 in Archives of Surgery
Verified
Journal Article
Closed access
PDF file
KFKazuhiko Fukatsu
Kazuhiko Fukatsu
HSHideaki Saito
Hideaki Saito
TMTakeaki Matsuda
Takeaki Matsuda
SIShigeo Ikeda
Shigeo Ikeda
SFSatoshi Furukawa
Satoshi Furukawa
TMTetsuichiro Muto
Tetsuichiro Muto
Objective: To clarify how antibiotic prophylaxis influenced an outbreak of methicillin-resistant Staphylococcus aureus (MRSA) and postoperative infection. Design: Retrospective review. Setting: University-affiliated teaching hospital. Patients: All patients (n = 1824) undergoing subtotal esophagectomy, gastrectomy, or colorectal surgery during the period 1982 through 1995. Main Outcome Measures: Type, timing, and duration of prophylactic antibiotics. Postoperative infection by the Centers for Disease Control and Prevention definition and the organisms isolated. Results: Third-generation cephalosporins were frequently administered for prophylaxis during the period 1982 through 1990. The rate of isolates of MRSA from the infected site increased, peaking in 1988 to 1990. Since 1991 to 1992, along with a marked decrease in third-generation cephalosporin use, the rates of MRSA isolated have declined dramatically. The timing of administration changed from postoperative to intraoperative. Although the duration was gradually decreased, coverage was still provided until about the fifth postoperative day, even during 1993 to 1995. Prolonged coverage did not reduce the rate of superficial incisional or organ/space surgical site infection or that of pneumonia. Conclusions: Overuse of third-generation cephalosporins for long periods caused an MRSA outbreak. Long-term prophylaxis did not lower infection rates. The briefest possible prophylaxis with first- or second-generation cephalosporins should be used in general surgery. Arch Surg. 1997;132:1320-1325

25 February 2019 in Annals of Gastroenterological Surgery
Verified
Journal Article
Open access
PDF file
KFKazuhiko Fukatsu
Kazuhiko Fukatsu
Nutrition plays important roles in recovery after gastroenterological surgery. Severe surgical stress increases muscle breakdown and lipolysis, thereby accelerating wound healing and enhancing host defense against microbes. Malnourished patients have insufficient amounts of muscle and body fat. Therefore, they may not appropriately respond to surgical stress. Perioperative nutritional therapy maintaining nutritional status reduces postoperative complications and accelerates recovery after surgery, particularly for malnourished patients. In addition, perioperative oral or enteral nutrition is now recommended for preserving host defense mechanisms against microbes. Lack of enteral nutrition impairs gut and hepatic immunity, systemic mucosal defense and peritoneal host defense, even when nutrient amounts supplied by parenteral nutrition are adequate. Thus, surgeons should avoid no oral or enteral nutrition periods. Supplemental administration of specific nutrients such as glutamine, arginine and ω‐3 fatty acids is termed “immunonutrition”, and is expected to reduce the morbidity of infectious complications and length of hospital stay. Nutritional therapy is important even after discharge to maintain body weight and compensate for abnormalities in the digestion and absorption of nutrients. Understanding the significance of nutrition in gastroenterological patients leads to better outcomes.

15 February 1997 in Journal of Surgical Research
Verified
Journal Article
Closed access
KFKazuhiko Fukatsu
Kazuhiko Fukatsu
HSHideaki Saito
Hideaki Saito
IHIlsoo Han
Ilsoo Han
SFSatoshi Furukawa
Satoshi Furukawa
YHYojiro Hashiguchi
Yojiro Hashiguchi
TMTetsuichiro Muto
Tetsuichiro Muto

1 July 2004 in Journal of Parenteral and Enteral Nutrition
Verified
Journal Article
Closed access
PDF file
KFKazuhiko Fukatsu
Kazuhiko Fukatsu
CUC Ueno
C Ueno
YMY Maeshima
Y Maeshima
EHE Hara
E Hara
HNH Nagayoshi
H Nagayoshi
HHH Hiraide
H Hiraide

5 April 2011 in Journal of Parenteral and Enteral Nutrition
Verified
Journal Article
Open access
PDF file
SMSatoshi Murakoshi
Satoshi Murakoshi
KFKazuhiko Fukatsu
Kazuhiko Fukatsu
JOJiro Omata
Jiro Omata
TMTomoyuki Moriya
Tomoyuki Moriya
MNMidori Noguchi
Midori Noguchi
IKIsamu Koyama
Isamu Koyama
Background: Parenteral nutrition (PN) causes intestinal mucosal atrophy, gut‐associated lymphoid tissue (GALT) atrophy and dysfunction, leading to impaired mucosal immunity and increased susceptibility to infectious complications. Therefore, new PN formulations are needed to maintain mucosal immunity. Short‐chain fatty acids have been demonstrated to exert beneficial effects on the intestinal mucosa. We examined the effects of adding butyric acid to PN on GALT lymphocyte numbers, phenotypes, mucosal immunoglobulin A (IgA) levels, and intestinal morphology in mice. Methods: Male Institute of Cancer Research mice (n = 103) were randomized to receive either standard PN (S‐PN), butyric acid–supplemented PN (Bu‐PN), or ad libitum chow (control) groups. The mice were fed these respective diets for 5 days. In experiment 1, cells were isolated from Peyer's patches (PPs) to determine lymphocyte numbers and phenotypes (αβTCR+, γδTCR+, CD4+, CD8+, B220+ cells). IgA levels in small intestinal washings were also measured. In experiment 2, IgA levels in respiratory tract (bronchoalveolar and nasal) washings were measured. In experiment 3, small intestinal morphology was evaluated. Results: Lymphocyte yields from PPs and small intestinal, bronchoalveolar, and nasal washing IgA levels were all significantly lower in the S‐PN group than in the control group. Bu‐PN moderately, but significantly, restored PP lymphocyte numbers, as well as intestinal and bronchoalveolar IgA levels, as compared with S‐PN. Villous height and crypt depth in the small intestine were significantly decreased in the S‐PN group vs the control group, however Bu‐PN restored intestinal morphology. Conclusions: A new PN formula containing butyric acid is feasible and would ameliorate PN‐induced impairment of mucosal immunity.

1 May 2003 in Journal of Parenteral and Enteral Nutrition
Verified
Journal Article
Closed access
PDF file
KFKazuhiko Fukatsu
Kazuhiko Fukatsu
CUC Ueno
C Ueno
YHY Hashiguchi
Y Hashiguchi
EHE Hara
E Hara
MKM Kinoshita
M Kinoshita
HHH Hiraide
H Hiraide